LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine

NCT01751048 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

NIH

Sponsor class

Conditions

Leishmaniasis

Interventions

BIOLOGICAL: GLA-SE
BIOLOGICAL: LEISH-F3
BIOLOGICAL: MPL-SE
DRUG: SE

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)